Back to Journals » Vascular Health and Risk Management » Volume 12

Development of proprotein convertase subtilisin/kexin type 9 inhibitors and the clinical potential of monoclonal antibodies in the management of lipid disorders

Total article views   Abstract views HTML views PDF downloads Totals
5,869 Dovepress* 2,929 1,948+ 707 4,877
PubMed Central* 0 992 425 992
Totals 2,929 2,940 1,132 5,869
*Since 10 November 2016
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 0 2

View citations on PubMed Central and Google Scholar